In Brief
Arc is essential for learning and memory and plays a role in diseases of cognition. Zhang et al. provide the first crystal structure of Arc, revealing its evolutionary origin from a retrotransposon and binding mechanism that underlies its synaptic function.
Accession Numbers

4X3X 4X3H 4X3I
INTRODUCTION
Information storage in the brain is mediated by changes in synaptic strength that require rapid de novo synthesis of mRNA and protein (Goelet et al., 1986) . Arc provides an exemplary molecule for studies of how the de novo response contributes to memory. Arc was identified based on its rapid transcriptional upregulation in models of learning (Link et al., 1995; Lyford et al., 1995) , and its transcription is tightly linked to neural activity that underlies information processing and storage (Guzowski et al., 1999) . Genetic deletion of Arc results in deficits of memory without altering behaviors essential for learning . Arc is a postsynaptic protein that associates with endocytic vesicular proteins to modulate the trafficking of AMPAtype glutamate receptors Shepherd et al., 2006) . Arc also binds CaMKII in the kinase inactive state, and this interaction targets Arc to synapses in accordance (inverse) with their history of activity, and underlies Arc's contribution to homeostatic maintenance of distributed synaptic weights (Okuno et al., 2012) . Arc contributes importantly to cell-wide homeostatic scaling (non-Hebbian) and synapse-specific (Hebbian) plasticity (Bé ïque et al., 2011; Jakkamsetti et al., 2013; Park et al., 2008; Waung et al., 2008) . Arc has been implicated in diseases of cognition where its action is thought to contribute to reduced synaptic strength. Inhibitory control of Arc translation is disrupted in fragile X mental retardation syndrome and unregulated expression of Arc contributes to enhanced mGluR-LTD (Niere et al., 2012; Park et al., 2008; Waung et al., 2008) . In Angelman syndrome, reduced ubiquitination of Arc may result in an increase of Arc-dependent synaptic downregulation (Greer et al., 2010) . Arc enhances the association of g-secretase with trafficking endosomes that process amyloid precursor protein (APP) to Aß peptide. This action of Arc creates activity-dependent increases of Aß that contribute to amyloid deposition (Wu et al., 2011) . Mutations of genes whose protein products can physically associate with Arc were identified in studies of sporadic and inherited schizophrenia Purcell et al., 2014 ).
Arc's functions have been challenging to understand in molecular detail because Arc is a single copy gene without identifiable family members or biochemically defined domains. For example, Arc is known to downregulate synaptic AMPA-type glutamate receptors, but the binding partners and regulatory mechanisms that couple Arc to AMPA receptor trafficking remain unknown. Arc's association with cognitive diseases suggests that knowledge of physical associations that define its binding properties could provide insight into pathogenesis. To address this challenge, we evaluated known interactions of Arc and assessed whether they could be reconstituted with recombinant proteins. We discovered that both full-length Arc, as well as a specific subdomain of Arc, bound CaMKII. This same subdomain of Arc was found to bind to TARPg2 (Stargazin), which is known to associate with AMPA receptors and mediate critical aspects of AMPA receptor trafficking (Jackson and Nicoll, 2011) . Co-crystal structures of an Arc subdomain bound to CaMKII and TARPg2 were defined and reveal the structural basis of these interactions. Physiological studies demonstrate that synaptic AMPA receptor downregulation during homeostatic scaling requires Arc N-lobe binding. Remarkably, the subdomain that mediates Arc binding is structurally similar to the capsid domain of human immunodeficiency virus (HIV). A structure of a second subdomain of Arc further substantiates a bi-lobar configuration that is similar to HIV GAG protein and indicates Arc originated from the Ty3/ Gypsy retrotransposon family. Analysis across species reveals the evolutionary origin of its unique binding domain. An Arc Nlobe consensus binding sequence was established that identifies several novel binding partners that include proteins of the ''Arc complex'' linked to schizophrenia Purcell et al., 2014) . Arc N-lobe binding is dependent on buried hydrophobic interactions that are notably distinct from many protein-protein interactions and this prompted us to screen for and identify small molecules that can inhibit Arc N-lobe binding. These observations provide a structural basis for understanding critical functions of Arc in synaptic plasticity and cognitive diseases and support the possibility that Arc functions may pharmacologically targetable.
RESULTS
Evolutionary Origin of Arc from Ty3/Gypsy Retrotransposon and Phyla-Specific Domestication
The Arc-CaMKII interaction was previously characterized in coimmunoprecipitation assays (Okuno et al., 2012) . We discovered the Arc-TARPg2 interaction in a survey of synaptic proteins that co-immunoprecipitate with Arc ( Figure S1A ). TARPg2 associates with AMPA receptors and modulates AMPA receptor trafficking and localization to the synapse (Jackson and Nicoll, 2011) . Rat Arc (Rn Arc) bound TARPg2 peptide (see Figure 2 ) and CaMKIIa peptide ( Figure S1B ) in vitro. Full-length RnArc did not crystallize, but crystallized in complex with TARPg2 and CaMKII peptides (Table S1 ). Crystal structures revealed RnArc (207-278) forms a four helical bundle ( Figure 1A ) that is structurally similar to capsid domains of retroviral gag proteins in the PDB database, including HIV and Rous Sarcoma Virus (RSV) (Figures 1A and 1C and Figures S2A and S2B) . No other structures were significantly similar. HIV capsid is typical of retroviruses and includes two globular domains termed NTD and CTD (Pornillos et al., 2009 (Pornillos et al., , 2011 . While sequence identity is only 11%, RnArc (207-278) superposes on the HIV CTD with a root-mean-square deviation (RMSD) of 2.6 Å for 61 includes an additional b1-strand at its N terminus that contacts the a1-helix and surrounds the bound TARPg2 peptide ( Figure 1A ). Similarity between Arc and HIV capsid protein was further borne out with the structure of RnArc (278-370) apoprotein (Table S1) , which is also superimposable with HIV capsid protein CTD. RnArc (278-370) possesses a more extensive a1' helix at the N terminus of the major homology region (MHR) than retroviruses ( Figures 1B and 1C) . We term Arc N-lobe, and RnArc (278-370) Arc C-lobe; together they form the Arc Gag domain.
Sequence analysis reveals bi-lobar Arc domains in all metazoans ( Figures 1C and 1D ). Arc is highly conserved in mammals, birds, and reptiles. The bi-lobar Arc domain in the fish Danio (Dr) appears in three genes that are members of the Ty3/Gypsy family of retrotransposons. Ty3/Gypsy are ancient forms of RNAbased self-replicating elements that are present in animal, plant, and fungal kingdoms and are considered ancestral to modern retroviruses, including HIV (Llorens et al., 2008) , as well as certain cellular genes (Campillos et al., 2006; Volff, 2009 ). The fish Danio Arc genes Dr1 and Dr3 encode domains typical of Retrotansposons including zinc knuckles, which bind RNA during virion assembly, as well as reverse transcriptase (RT) ( Figure 1D ). These observations confirm computational predictions of Arc's retrotransposon origin (Campillos et al., 2006) . Danio gene Dr2 is different from Dr1 and Dr3 in that it possesses an N-terminal coiled-coil domain, which is typical of all higher vertebrate Arc genes, and lacks the zinc knuckle domain. This suggests that vertebrate Arc arose through the ''domestication'' (repurposing of retrotransposon genes in eukaryotic cells; see Campillos et al., 2006) of Ty3/Gypsy in stages that include acquiring the N-terminal coil-coil and loss of the zinc knuckle and RT.
The Arc bi-lobar domain is also present in insects. Arc in beetle Tribolium castaneum (Tca) includes zinc knuckles and reverse transcriptase, while Drosophila Arc1 protein includes zinc knuckles but lacks reverse transcriptase ( Figure 1D ). Insect Arc lacks the N-terminal CC domain typical of vertebrate Arc. This suggests that Arc domestication in insects followed a different functional path and is consistent with studies of Dme Arc that define a role in stress-induced behavior but not learning and memory (Mattaliano et al., 2007) .
A retrotransposon is present in plant Fragaria vesca that possesses $14% identity to RnArc within the GAG domain. However, this plant gene appears to be a different family of retrotransposon based on sequence of the nucleotide binding domain encoding CHHC zinc knuckle motif, not CCHC motif ( Figure 1E ).
Determinants of Arc N-Lobe Structure Important for Binding to TARPg2
We examined determinants of Arc binding to TARPg2. TARPg2 passes through the hydrophobic core of the Arc N-lobe four helix bundle (Figures 2A and 2B ). The small A250 side chain together with P217 creates space for interactions with TARPg2 Y229 aromatic ring. RnArc (207-370) mutations P217F and P217V that fill the pocket and mimic Dme Arc or retroviral Gag ( Figure 1C ) abolish binding to TARPg2 peptide ( Figure 2C ). Thus, TARPg2 Y229 appears to replace an aromatic stack that assembles the four helices of retroviral/HIV Gag proteins. Arc strand b1, loop T3, and the N terminus of helix a3 create a groove that surrounds the peptide (Figures 2A and 2B ). This groove also appears important for binding since RnArc (207-370) F214S, which mimics Xenopus Arc and encodes an aromatic pocket but not the aromatic pair F214-H223 required to anchor b1 strand to helix a1, fails to bind ( Figure 2C ). As predicted, Xenopus Arc does not bind TARPg2 ( Figure S3A ). The evolutionary origin and progression suggest Arc N-lobe binding is unique to the vertebrate genome.
To further assess determinants of peptide binding, we devel- (A and B) Superposition of Arc N-lobe or C-lobe (blue and orange, respectively) with HIV capsid C-lobe (PDB: 1A43; yellow). The RMSD in C a positions for superposition of the N-lobe (excluding residues 207-214) and C-lobe are 2.6 and 2.3 Å , respectively. The TARPg2 peptide complexed with Arc N-lobe is colored purple. Helix labels in parentheses followed the reference for HIV capsid domain (Pornillos et al., 2009 (Pornillos et al., , 2011 .
(C) The sequence alignment for typical species based on their 3D structural superposition with retrotransposon or retrovirus (PDB: 1A43, HIV capsid C-lobe; 3G29, Rous Sarcoma Virus). Hs, Homo sapiens, Genbank: NP_056008.1; Rn, Rattus norvegicus, Genbank: NP_062234.1; Gga, Gallus gallus, Genbank: NP_989763.1; Aca, Anolis carolinensis, XP_003223977.1; Xtr, Xenopus (Silurana) tropicalis, XP_002934511.1; Dme, Drosophila melanogaster, Arc1, Q7K1U0; Dr2, Danio rerio, XP_001919627; _N and _C refer to N-lobe and C-lobe, respectively. Secondary structures of Arc N-lobe and HIV C-lobe (PDB: 1A43) are shown on the top in red and blue, respectively. Arc C-lobe secondary structure is on the bottom. Residues forming the hydrophobic pocket in Arc N-lobe are marked with a red star above the sequence alignment. The pair of aromatic residues anchoring N-terminal beta strand on alpha helix bundle core is highlighted with yellow solid circles. The numbers in the box indicate three categories (1, N-lobes; 2, Virus; 3, C-lobes). The conservative residues across different species are marked in gray. ArcP217F ( Figure 3A ). Transgene expression was also monitored by co-expression of GFP, which was typically detected in $80% of neurons (data not shown). Neurons were treated with TTX to suppress synaptic activity, and thereby reduce expression of native Arc , during viral gene expression (12-16 hr). Consistent with previous studies, WT Arc transgene reduced expression of AMPA receptor GluA1 on the membrane surface as assayed by biotinylation of surface proteins (Figures 3A and 3B) . TARPg2 was also prominently downregulated by WT Arc, consistent with its role as a binding partner of GluA1 and regulator of trafficking. By contrast, ArcP217F did not downregulate surface GluA1 or TARPg2. Since Arc does not bind GluA1 directly , this supports the hypothesis that Arc binding to TARPg2 mediates GluA1 downregulation. Recordings from viral-transfected neurons confirmed that the mEPSC amplitude and frequency were reduced in neurons expressing WT Arc compared to ArcP217F ( Figure 3C ). These data establish that Arc-N lobe binding is essential for Arc-dependent downregulation of synaptic strength. It should be noted that the larger amplitude of mEPSCs in ArcP217F increases detection and leaves open the question of whether there are truly more synapses or just more detected.
Ligand Determinants Reveal Regulatory Mechanisms and Consensus Sequence for Arc Binding
An electron density map of the bound TARPg2 peptide reveals features of the ligand that are important for binding ( Figure 4A ). Hydrogen bonds are present to both main chain and side chain positions ( Figure 4B ). TARPg2 is a member of type I TARPs, which include TARPg3, TARPg4, and TARPg8 (Tomita et al., 2003) . The Arc binding motif is conserved in TARPg4 and TARPg8, but TARPg3 encodes proline rather than serine at position 228 in higher vertebrates ( Figure S3B ). This substitution interferes with b strand formation. RnArc (207-370) bound GST-TARPg2 but not GST-TARPg3 ( Figure 4C ), consistent with a requirement for b strand. The non-binding form of TARPg3 appears to be an evolutionary adaptation in higher vertebrates since Xenopus and Danio TARPg3 encode S228 (Figure S3B ). Another regulatory mechanism is suggested by the observation that TARPg2 is dynamically phosphorylated and dephosphorylated in association with synaptic potentiation or depression, respectively (Opazo et al., 2010; Sumioka et al., 2010; Tomita et al., 2005) . One of these phosphorylation sites TARPg2(S228) ( Figure S3B ) is predicted to disrupt hydrogen bonds made by the side chain hydroxyl and introduce steric clashes with I213 and N247 ( Figure 4B ). RnArc (207-370) bound GST-TARPg2 but not a TARPg2 peptide with phosphomimetic substitutions (Sumioka et al., 2010) (Figure 4D and Figure S3B ).
We used the FP competition binding assay to assess determinants of binding affinity. We began by examining effects of mutations of the TARPg2 peptide on Arc binding. Phosphorylation of TARPg2(S228) or TARPg2(Y229) reduced binding affinity at least 20-fold ( Figure 4E) . A minimal tripeptide corresponding to the central PSY sequence failed to bind, suggesting that a basic and long b strand conformation is important for interaction. Cam-KII peptide (ATRNFS) is notably distinct from TARPg2 in that R substitutes for P. While this peptide occupies the same position in the co-crystal ( Figure S3C ), the affinity of binding is $760 mM ( Figures S3C and S3D ), consistent with TARPg2(P227R) (Figure 4E ). These observations predict a consensus sequence P [STVILMKR] [FYH] in the basic context of a b strand secondary structure. The consensus is similar but distinct from binding sites for phosphotyrosine binding domain (PTB) (Zhou et al., 1996) or FERM domain (Brahme and Calderwood, 2012) proteins.
A search of the Swiss-Prot protein database for Arc N-lobe consensus identified several synaptic proteins. We focused on proteins that were recently implicated in genetic studies of schizophrenia Purcell et al., 2014) since several reportedly co-precipitate with tandem affinity tagged Arc or NMDA receptor (including CaMKIIa and b) (Ferná ndez et al., 2009; Husi et al., 2000) or play a role in actin dynamics (Figure 5A and Figure S5D ). To assess whether these are natural binding partners of Arc N-lobe, we expressed representative proteins IQSEC2 (aa 1,329-1,385) and WAVE1 (aa 301-343) as GST-fusion proteins and determined that they bind Arc N-lobe ( Figure S4 ). FP assays confirmed Arc binding to WAVE1, GKAP, IQSEC2, and GluN2A and estimated their affinity of binding from 11 mM to 160 mM ( Figure 5B ). GST pull-down assays using Arc N-lobe versus ArcP217F N-lobe with native proteins from brain detergent lysates confirmed specific binding ( Figures 5C and 5D ). Natural association was confirmed in co-immunoprecipitation assays from brain comparing lysates from WT versus Arc À/À forebrain ( Figure S4) . Arc N-Lobe Binding Is Inhibited by Chemical Pharmaceuticals The robust FP assay afforded an opportunity to screen for chemical agents that might inhibit Arc-N-lobe binding. Typical protein-protein interactions that are mediated by relatively large, flat surfaces are difficult to inhibit; however, the peptide binding groove and hydrophobic pocket required for Arc Nlobe binding suggested that chemical agents might inhibit binding. We screened a library of FDA approved compounds ($2,700) (Chong et al., 2007) and initial positives (20) were rescreened for inhibition of binding to TARPg2 (221-247) ( Figures S5A and S5B ). Thioridazine inhibited binding with an IC 50 of 194 mM; $80% of binding inhibited over 1 log [Thioridazine] ( Figure 5E ). The structurally related phenothiazine Trifluoperazine also inhibited binding but with lower affinity (Figure S5C) , while Chlorpromazine, which has no hexatomic ring to mimic the aromatic group of side chain in the Arc binding motif, did not (data not shown). This SAR together with the low IC 50 , which for Thioridazine is $10 4 lower than for D2 dopamine re- ceptors (Cohen et al., 1979) , indicates that inhibition of Arc N-lobe binding is not related to antipsychotic action. These observations support the feasibility of pharmacological interruption of Arc binding but also highlight the challenge of specificity.
DISCUSSION
The present study provides the first atomic structure for Arc and reveals that Arc N-and C-lobes evolved from the capsid domain of Ty3/Gypsy retrotransposon. Ty3/Gypsy sequence homologs are recognized by computational methods in nearly 100 mammalian proteins, and many of these derive from the Ty3/Gypsy Gag domain (Campillos et al., 2006) . Arc is the only synaptic protein of this class and its structure provides the first structural information beyond HIV for this group of genes. In addition to revealing evolutionary adaptations that underlie synaptic functions of Arc, comparison of Arc N-lobe with HIV NTD reveals evolutionary adaptations that probably contribute to flexibility between HIV NTD and CTD ( Figure S2 ), which is important for its unique capsid structure (Pornillos et al., 2009 (Pornillos et al., , 2011 . Arc mRNA and protein expression exhibit several unusual and dynamic regulatory mechanisms that may be related to Arc's retrotransposon origin (Volff, 2009) . Like viral genes, Arc mRNA possesses an internal ribosome entry sequence (IRES) (Pinkstaff et al., 2001) , and Arc is rapidly translated in dendrites in response to signals that inhibit general mRNA translation (Park et al., 2008) . Trafficking of Arc mRNAs to distal dendrites (Steward et al., 1998) shares cell biological challenges of retroviral RNA trafficking from the nucleus to the cell cortex where Gag protein must assemble at the plasma membrane (Cochrane et al., 2006; Shida, 2012) . Host defenses against viruses include incorporation of introns in the 3 0 UTR to engage non-sense-mediated decay (NMD) (Isken and Maquat, 2007) and microRNAs (Umbach and Cullen, 2009 ). Arc mRNA is regulated by both mechanisms (Giorgi et al., 2007; Huang et al., 2012) . Emergence of Arc as a cellular IEG provides a compelling example of retrotransposon-host co-evolution.
Arc N-lobe binding function emerges via amino acid substitutions that interrupt an intramolecular aromatic stack at the center of the four helix bundle and consequently create a unique hydrophobic pocket that together with a b sheet binding groove mediates intermolecular binding. Arc binding to TARPg2 defines a protein assembly that presumably includes AMPA receptors and can mediate Arc-dependent downregulation of AMPA receptors during homeostatic scaling. Structural features of ArcTARPg2 binding and peptide binding experiments predict that the interaction is regulated by phosphorylation of TARPg2, which is consistent with physiological effects of TARPg2 phosphorylation to increase synaptic strength (Opazo et Arc may also be controlled at the level of TARP gene expression since TARPg3 evolves to escape Arc binding in higher vertebrates. Arc-N lobe binding to CaMKII is relatively low affinity but consistent with the high concentration of CaMKII at synapses, and with a model in which Arc binding to CaMKII targets Arc to inactive synapses (Okuno et al., 2012) . Identification of an Arc N-lobe consensus binding motif expands the protein interaction network for Arc. The functional role for each of these interactions remains to be defined, but a model of binding and downregulation similar to action with TARPg2-AMPA receptor is consistent with activity-dependent downregulation of synaptic NMDA receptors (Watt et al., 2004) , GKAP (Shin et al., 2012) , and Arc-dependent changes in spine structure (Greer et al., 2010; Peebles et al., 2010) .
The present study provides structural information about the C-terminal half of Arc that includes a region previously suggested to possess homology with spectrin repeats (Lyford et al., 1995) . We were not able to crystalize full-length Arc, and consequently the structural basis of several critical functions of Arc remain unknown. For example, Arc interactions with endophilin and dynamin are required for its synaptic function; however, these interactions are not defined in the present study as they require a region of the N-terminal half of Arc . Based on sequence analysis, we hypothesize the Arc N-terminal half includes a-helical regions and mediates associations with phospholipids and endocytic proteins. In this model, Arc N-lobe defines the target specificity in Arc-dependent trafficking of specific proteins from the plasma membrane and cytosol in endocytic vesicle pathways.
The Arc N-lobe binding consensus is similar to the NPXY sequence that is present in the cytosolic domains of several transmembrane proteins important in synaptic function including integrins, growth factor receptors, LDL receptor family, and amyloid precursor protein (APP) (Chen et al., 1990; Pandey, 2010) . The NPXY motif is bound by proteins that encode phosphotyrosine binding domains (PTB) and FERM domains, which function in cargo recognition to regulate endocytosis, trafficking, and function of the transmembrane proteins (Traub and Bonifacino, 2013) . In some (but not all) cases, PTB binding is regulated by tyrosine phosphorylation or receptor ubiquitination (Goh and Sorkin, 2013) , and instances of dynamic competition between multiple binding partners are described (Brahme and Calderwood, 2012) . Crystal structures of NPXY bound to PTB/FERM domains reveals distinct binding mode and conformation of the ligand compared to Arc N-lobe (Dvir et al., 2012; Ghai et al., 2013) . Nevertheless, Arc might represent a competitive mechanism for binding and alternative endocytic trafficking for these membrane proteins.
Arc N-lobe binding partners include protein products of genes linked to schizophrenia Purcell et al., 2014) . In genetic studies of schizophrenia, certain genes were grouped as part of an Arc complex based on their co-precipitation with tagged Arc, while other genes were grouped as part of a separate NMDA receptor complex or of an actin dynamics complex. Since mutations are rare in schizophrenia patients, grouping is important to reach a statistical association with disease. Arc Nlobe binding provides an alternative criterion for clustering genes linked to schizophrenia that merges components of each of these three groupings. Nearly half of the synaptic genes with large deletions associated with schizophrenia (see extended data Table 3 in Purcell et al., 2014) possess an Arc N-lobe consensus binding sequence ( Figure S5D ). To date, mutations reported in schizophrenia do not implicate Arc itself, which together with the present data, suggests the shared property of rare mutations linked to schizophrenia may be that they result in accentuation of processes mediated by Arc that downregulate neuronal excitability at individual synapses (Bé ïque et al., 2011; Jakkamsetti et al., 2013; Park et al., 2008; Waung et al., 2008) or in cell-wide adaptations to altered cellular or network activity . The observation that Arc-N lobe binding can be inhibited by chemical pharmaceuticals suggests that the action of Arc to downregulate synaptic proteins may be a feasible target for therapeutics although it remains to be seen if agents with sufficient specificity can be discovered. Our studies anticipate the development of genetic and pharmacological tools to test the hypothesized role of Arc in physiology and disease.
EXPERIMENTAL PROCEDURES Expression Constructs and Antibodies
All the expression constructs were made by PCR and the PCR products were cloned into expression vectors pGEX-6P-1 (GE Healthcare) or pSinRep5 (Invitrogen). Point mutants were made using Quick Change Site-Directed Mutagenesis Kit (Stratagene). The sequence of the primers used to generate each mutant will be supplied upon request. All constructs were verified by DNA sequencing.
GluA1 antibody was kindly provided by Dr. Richard Huganir (Johns Hopkins University). Monoclonal Arc antibody was generated in Monoclonal Antibody Core at Johns Hopkins University using Arc C-terminal (155-396) as antigen.
The other antibodies were purchased from commercial sources: Stargazin (Millipore), b-actin (Sigma).
Protein Expression and Purification
The cDNAs of Rn Arc (Genbank: NP_062234) N-lobe and C-lobe domains (residues 207À277 and 278À370, respectively) were subcloned into vector pGEX-6P-1 (GE Healthcare) between the EcoRI and XhoI restriction sites for bacterial expression as a GST-fusion protein. The transfected E. coli BL21(DE3) cell culture was grown at 37 C until OD 600 nm reached 0.6. The temperature was reduced to 25 C, and cells were induced with 0.2 mM isopropyl-b-D-thiogalactopyranoside (IPTG) and grown for 16 hr. The cells were harvested and lysed by sonicating in PBS (pH 7.3) supplemented with 1% Triton X-100. The recombinant protein in the supernatant of the cell lysate was mixed with Glutathione Sepharose resin (GE Healthcare), and the mixture was washed extensively in PBS with 1% Triton X-100. After cleaving with Precision protease overnight to remove the GST tag, the protein was purified by using Q Sepharose Fast Flow and Superdex 75 size-exclusion chromatography, and was exchanged into a buffer of 20 mM Tris-HCl (pH 8.0), 100 mM NaCl, and 1 mM DTT (dithiothreitol) and was concentrated to 15 mg/ml immediately before crystallization. Selenomethionyl-substituted protein was expressed and purified as WT. All point mutants of RnArc (207-370) were expressed and purified similarly to the WT. The cDNAs of mouse TARPg2 (Genbank: NP_031609) cytoplasmic region (residues 203À323, 203-247, and 221À247, respectively) , TARP g-3 (Genbank: NP_062303) cytoplasmic region (residues 202-249), IQSEC2 fragment (aa 1,329-1,385, Genbank: NP_001108136) and WAVE1 (aa 301-343, Genbank: NP_114083) and CAMK2A peptide (Genbank: NP_803126, residues 278-329) were cloned from a mouse brain cDNA library. The cDNA clone of Xenopus tropicalis Arc (XP_004918984, residues 168-266) was obtained from Dr. Sabrina S. Burmeister of University of North Carolina Department of Neurobiology (Mangiamele et al., 2006) . These constructs were subcloned into vector pGEX-6P-1 (GE Healthcare) between the EcoRI and XhoI restriction sites for expression in E. coli. The construct of the GST-fusion S9D was obtained from Dr. Susumu Tomita of the Yale University School of Medicine (Sumioka et al., 2010) . All recombinant proteins contained an N-terminal GST-tag and were purified with GSH-affinity chromatography. (221-247) and CaMKIIa peptide (278-329) were further purified by SP Sepharose Fast Flow after removing the GST tag.
Crystallography Studies
Recombinant protein Arc C-lobe (278-370) was crystallized using the hanging drop vapor diffusion method. The protein sample ($15 mg/ml) was mixed with an equal volume (2+2 ml) of the precipitant solution containing 1 M sodium citrate and 0.1 M imidazole (pH 8.0). The best-diffracting crystals grew as plates to their maximum size of 0. For the crystal of Arc C-lobe and co-crystal of Arc N-lobe with CaMKIIa peptide, X-ray diffraction data were collected at beamline 23-ID at the Argonne National Laboratory from a flash-cooled crystal after soaking the crystal in a cryo-protectant solution containing 15% (v/v) glycerol. For the complexed crystal of Arc N-lobe with fragment, X-ray diffraction data were collected on Rigaku FR-E X-ray generator with the detector of a Saturn 944+ CCD. Data were processed, scaled, and merged using the HKL2000 program package (Otwinowski and Minor, 1997) .
Phases of the Arc C-lobe crystal structure and the co-crystal of Arc N-lobe with CaMKIIa peptide were solved by the Se-based single-wavelength anomalous dispersion method (Hendrickson and Ogata, 1997) 39393938 using the program PHENIX (Adams et al., 2010) and the data at the Se-absorption edge. The electron density map calculated at 2.0 Å resolution was readily interpretable.
Model building was performed using the program COOT (Emsley and Cowtan, 2004) guided by 2F o ÀF c and F o ÀF c difference Fourier electron density maps. Atomic coordinates were refined with iterative cycles of manual building using COOT (Emsley and Cowtan, 2004) , REFMAC (Vagin et al., 2004) , and PHENIX (Adams et al., 2010) . Phases of the crystal structure of the Arc N-lobe-complex were determined by the molecular replacement method using the program MOLREP (Vagin and Teplyakov, 2010) and the Arc N-lobe complex with CaMKIIa peptide as the search template, and refined similarly as above. Final X-ray data collection and refinement statistics are presented in Table S1 . All structure figures were prepared with program Pymol (Schrö dinger).
Fluorescence Polarization Assay 5-Carboxyfluorescein (FAM) labeled peptide (RIPSYR) (GenScript) was dissolved in 10 mM Tris-Cl (pH 8.0), 0.5% NP-40 and 100 mM NaCl. Purified wild-type or mutant Arc (202-370) protein samples were diluted with the above buffer and mixed with 5 nM FAM labeled peptides. The mixtures were assayed in black 384 well plates with the Tecan Safire2 Microplate Reader (Tecan Group). Data were analyzed and plotted using program GraphPad Prism version 5.0 (GraphPad Software). Fluorescence polarization competition assay followed protocol (Moerke, 2009; Roehrl et al., 2004) using synthesis peptides of various TARPg2 mutant, GKAP (aa 436-441, NP_808307), WAVE1 (aa 315-320, NP_114083), NR2A (aa 1,169-1,174, NP_032196), and purified fragment of IQSEC2 (aa 1,329-1,385, NP_001108136).
GST Pull-Down Assay E.coli expressed GST or GST fusion protein that is immobilized on glutathioneSepharose beads was used to incubate with E.coli expressed protein or brain lysate at 4 C for 4 hr to overnight. After incubation, glutathione-Sepharose beads were washed with 0.5$1.0% Triton X-100 buffer (in PBS) three times. Elutes from beads were used for either SDS-PAGE gel electrophoresis and Coomassie blue staining or western blotting with specific antibody.
Co-Immunoprecipitation C57BL/6 mouse brain was sonicated in 20 volumes of lysis buffer (PBS [pH 7.4], 1% Triton X-100, 5 mM EDTA, 5 mM EGTA) containing Complete EDTA-Free protease inhibitor (Roche) and PhosSTOP phosphatase inhibitor (Roche). The brain lysate was centrifuged at 161,000 3 g for 15 min and the supernatant was mixed with 1 mg Arc monoclonal antibody for 4 hr at 4 C.
Then, 60 ml of 50% Protein G Sepharose slurry (Amersham-Pharmacia Biotech) was added for an additional 2 hr. The protein beads were washed three times with lysis buffer containing 1% Triton X-100. The protein samples were eluted with SDS loading buffer and analyzed by gel electrophoresis and western blotting.
Recombinant Sindbis Virus Production and Infection
Arc WT or Arc P217F was subcloned into pIRES2-EGFP vector and then transferred into pSinRep5 (Invitrogen). All constructs were verified by sequencing.
To generate pseudovirions, we first generated recombinant RNA and helper RNA using mMESSAGE mMACHINE SP6 Transcription kit (Ambion). Sindbis pseudovirions were produced following the manufacture protocol for Sindbis Expression System (Invitrogen). At 11-14DIV, cultured neurons were infected with virus. Experiments were performed 12-16 hr after infection.
Primary Cortical Neuronal Culture
High-density cortical cultures from embryonic day 18 (E18) C57/Bl6 mouse pups were prepared as reported previously (Wu et al., 2011) with minor alterations. For surface biotinylation experiments, 1 3 10 6 neurons were added to each well of a 6-well plate (Corning) coated with poly-L-lysine. For recording experiments, 2 3 10 6 neurons were added to each 60 mm dish (Corning) with coverslips coated with poly-L-lysine. Growth medium consisted of NeuroBasal (Invitrogen) supplemented with 1% fetal bovine serum (Hyclone), 2% B27, 1% Glutamax (Invitrogen), 100 U/ml penicillin, and 100 U/ml streptomycin (Invitrogen). Neurons were fed twice per week with glia conditioned growth medium.
Surface Biotinylation Assay
For surface biotinylation, infected cortical neurons were cooled on ice, washed twice with ice-cold PBS containing 1 mM CaCl 2 and 0.5 mM MgCl 2 , and then incubated with PBS containing 1 mM CaCl 2 , 0.5 mM MgCl 2 , and 1 mg/ml Sulfo-NHS-SS-Biotin (Pierce) for 30 min at 4 C. Unreacted biotin was quenched by washing cells three times with ice-cold 100 mM glycine (pH 7.4). Cultures were harvested in RIPA buffer. Cell lysate was sonicated and centrifuged at 132,000 rpm for 20 min at 4 C. 15% of the resulting supernatant was saved as the ''total'' protein samples. The remaining 85% of the lysate was rotated overnight at 4 C with NeutrAvidin beads (Pierce). Precipitates were washed with RIPA buffer and analyzed by western blotting with indicated antibodies.
Electrophysiology and mEPSC Analysis
Whole-cell patch-clamp recordings were performed from cortical cultures. To isolate AMPAR-mediated mEPSCs, we continuously perfused neurons with artificial cerebral-spinal fluid (aCSF) including 124 mM NaCl, 2.5 mM KCl, 2.5 mM CaCl 2 , 1.3 mM MgCl 2 , 26.2 mM NaHCO 3 , 10 mM glucose, 0.01 mM gabazine, and 0.001 mM tetrodotoxin. Intracellular saline consisted of the following: 135 mM Cs-MeSO 4 , 10 mM CsCl, 10 mM HEPES, 5 mM EGTA, 2 mM MgCl 2 , 4 mM Na-ATP, and 0.1 mM Na-GTP adjusted to the osmolarity of 305-310 and 7.3-7.4 pH. Transfected neurons were selected based on fluorescent (eGFP) signal. Once the whole-cell recording configuration was achieved, neurons were voltage clamped, and passive properties were monitored throughout. In the event of a change in series resistance (Rs) or input resistance (Ri) >15% during the course of a recording, the data were excluded from the set. mEPSCs were acquired through a MultiClamp 700B amplifier (Axon Instruments), filtered at 2 kHz, and digitized at 5 kHz. Sweeps of 20 s with zero latency were acquired until a sufficient number of events were recorded (a minimum of 5 and no longer than 30 min). Data were recorded continuously only after a period of 5 min, during which the cell was allowed to stabilize. mEPSCs were detected manually with miniAnalysis software (Synaptosoft) by setting the amplitude threshold to O RMS 3 3 (usually 4 pA). Once a minimum of 100 events had been collected from a neuron, the amplitude and frequency were measured. In all electrophysiological experiments, a similar amount of data was acquired from both Arc WT and Arc P217F overexpressing neurons on the same day. Data from each group were then averaged and statistical significance was determined by Student's t test.
ACCESSION NUMBERS
Atomic coordinates and X-ray structure factors have been deposited in the Protein Data Bank with accession numbers PDB: 4X3X (Arc C-lobe), PDB: 4X3H (Arc N-lobe with TARPg2 peptide) and PDB: 4X3I (Arc N-lobe with CaMKIIa peptide). 
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